Direct-to-consumer services: improving access to care for people with diabetes and obesity
When Eli Lilly started its US direct-to-consumer service earlier this year, it did so with the stated aim of offering “patients an innovative end-to-end experience to manage their health and access their medicines”. LillyDirect’s initial focus is on diabetes, migraine, and obesity, although Lilly has said that the service will “continue to be updated and expanded”. The site allows users to arrange home delivery of their prescribed Lilly product. People with diabetes, for example, can fill their prescription for Lilly’s fast-acting analogue insulin, Humalog.